14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $3.81 $4.85 Wednesday, 1st May 2024 NVAX stock ended at $4.67. This is 7.85% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 11.89% from a day low at $4.29 to a day high of $4.80.
90 days $3.53 $6.05
52 weeks $3.53 $11.36

Historical Novavax Inc prices

Date Open High Low Close Volume
Jul 17, 2023 $8.70 $8.74 $8.14 $8.16 4 307 951
Jul 14, 2023 $9.21 $9.23 $8.51 $8.68 5 471 592
Jul 13, 2023 $9.38 $9.47 $9.16 $9.24 3 945 668
Jul 12, 2023 $9.88 $9.91 $9.28 $9.34 5 380 960
Jul 11, 2023 $9.11 $10.18 $8.85 $9.62 14 683 247
Jul 10, 2023 $7.35 $9.55 $7.30 $9.36 28 038 493
Jul 07, 2023 $7.05 $7.34 $7.05 $7.23 3 149 061
Jul 06, 2023 $7.25 $7.34 $6.90 $7.06 4 075 925
Jul 05, 2023 $7.38 $7.46 $7.21 $7.36 3 013 851
Jul 03, 2023 $7.48 $7.58 $7.22 $7.38 2 148 086
Jun 30, 2023 $7.62 $7.76 $7.39 $7.43 3 398 145
Jun 29, 2023 $7.53 $7.83 $7.45 $7.59 4 955 367
Jun 28, 2023 $7.17 $7.59 $7.03 $7.53 6 313 996
Jun 27, 2023 $6.69 $7.12 $6.59 $7.08 3 615 174
Jun 26, 2023 $6.71 $6.83 $6.56 $6.67 3 789 346
Jun 23, 2023 $7.10 $7.14 $6.61 $6.70 14 585 750
Jun 22, 2023 $7.39 $7.40 $7.07 $7.16 4 695 209
Jun 21, 2023 $7.48 $7.69 $7.16 $7.44 4 027 582
Jun 20, 2023 $8.06 $8.06 $7.23 $7.47 8 157 726
Jun 16, 2023 $8.20 $8.33 $7.89 $8.04 6 272 354
Jun 15, 2023 $7.72 $8.42 $7.65 $8.06 5 961 119
Jun 14, 2023 $8.19 $8.29 $7.69 $7.72 5 873 770
Jun 13, 2023 $7.85 $8.53 $7.74 $8.04 7 049 672
Jun 12, 2023 $7.62 $7.96 $7.47 $7.78 4 232 203
Jun 09, 2023 $7.74 $8.20 $7.45 $7.47 5 487 308
Click to get the best stock tips daily for free!

About Novavax Inc

Novavax Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical tria... NVAX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT